MarketBeat
14 May 2026, 04:14 UTC · 18w ago
Verdict
Headline takes no side. We score STAA +0.90 across six claims — strongly bullish.
+0.90strongly bullish
More positive than 94% of ticker scores this week
What the story claims
6 claims · scored −1 bearish … +1 bullish
STAAR reported Q1 net sales of $93.5 million (up 119.6% YoY) and adjusted EBITDA of $24.4 million, swinging from a $26.3 million adjusted EBITDA loss in the prior-year quarter.
So whatA massive YoY revenue surge and a definitive swing to profitability signal a fundamental recovery in the business trajectory, strongly boosting valuation multiples.
More positive than 99% of claims this week
STAAR declined to provide formal revenue guidance for 2026 or endorse consensus estimates, citing macroeconomic and geopolitical uncertainty.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 93% of claims this week
STAAR received FDA approval expanding the EVO ICL indication to patients aged 45 to 60, opening the product to roughly 8 million additional potential patients in the U.S.
More positive than 86% of claims this week
China inventory levels are now normalized and aligned with contractual targets, with sales to the market approximating sales into the market during the quarter.
More positive than 84% of claims this week
Which stocks this story touches
More positive than 94% of ticker scores this week
Reported a sharp rebound in sales and profitability, significant net income growth, and strong demand in China and the U.S.
Near neutral — 90% of ticker scores this week are stronger
Mentioned only as a reference to a past potential merger process with no current impact on its business operations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2d ago
−29.2%
Price is moving against the score
$20.82 vs $29.40 close before publication (May 13) · not market-adjusted
STAA chart →
